Clinical Trials Directory

Trials / Completed

CompletedNCT04812795

Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,214 (actual)
Sponsor
Abramson Cancer Center at Penn Medicine · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.

Detailed description

This study will recruit 2000 young adult sexual minority women (SMW), ages 18-30 years, current smokers (n = 1000) and not current smokers (n=1000). The study team will randomly assign participants to a condition in which they will be exposed to either culturally tailored anti-smoking messages or non-tailored. Participants will receive these messages at baseline and 1, 2, and 3 weeks post baseline. They will be asked to complete a follow-up survey one month post baseline. Intentions to quit smoking as well as intention (among current smokers) and intention to purchase cigarettes (among current nonsmokers) will be measured at baseline and one-month post baseline.

Conditions

Interventions

TypeNameDescription
OTHERCulturally tailored anti-smoking messagesAnti-smoking messages that are culturally tailored for sexual minority women.
OTHERNon-culturally tailored interventionsAnti-smoking messages that are not culturally tailored for sexual minority women.

Timeline

Start date
2021-09-08
Primary completion
2022-05-05
Completion
2022-06-20
First posted
2021-03-24
Last updated
2023-11-15
Results posted
2023-08-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04812795. Inclusion in this directory is not an endorsement.